Esrum Biotech ApS: Financial statements 2023
CVR: 43131761
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Esrum Biotech ApS (CVR 43131761) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,008,743 and a net result of DKK 1,458,238. Equity in the 2023 report amounted to DKK 2,386,975. The solvency ratio was 78.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,008,743
- Profit/Loss
- DKK 1,458,238
- Equity
- DKK 2,386,975
- Total Assets
- DKK 3,044,392
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Esrum Biotech ApS has published its interim report for the period March 15, 2022 – December 31, 2022.
About Esrum Biotech ApS
Esrum Biotech ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2022. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mette Kirstine Agger. The company is owned by Esrum Biotech Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 246,808 and a net result of DKK 95,817 compared with DKK 1,202,026 the year before. Equity in the 2025 report amounted to DKK 135,817.